nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—DRD2—Gilles de la Tourette syndrome	0.441	0.564	CbGaD
Ergotamine—HTR2A—Gilles de la Tourette syndrome	0.34	0.436	CbGaD
Ergotamine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00619	0.105	CbGeAlD
Ergotamine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00372	0.0631	CbGeAlD
Ergotamine—HTR1F—nervous system—Gilles de la Tourette syndrome	0.00239	0.0405	CbGeAlD
Ergotamine—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.0023	0.039	CbGeAlD
Ergotamine—HTR1E—nervous system—Gilles de la Tourette syndrome	0.00207	0.0351	CbGeAlD
Ergotamine—HTR1E—central nervous system—Gilles de la Tourette syndrome	0.00199	0.0338	CbGeAlD
Ergotamine—HTR1F—brain—Gilles de la Tourette syndrome	0.00182	0.031	CbGeAlD
Ergotamine—HTR1E—brain—Gilles de la Tourette syndrome	0.00158	0.0268	CbGeAlD
Ergotamine—Ergoloid mesylate—DRD2—Gilles de la Tourette syndrome	0.00154	0.176	CrCbGaD
Ergotamine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00129	0.022	CbGeAlD
Ergotamine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00127	0.0215	CbGeAlD
Ergotamine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00125	0.0212	CbGeAlD
Ergotamine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00122	0.0207	CbGeAlD
Ergotamine—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00119	0.0202	CbGeAlD
Ergotamine—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00115	0.0196	CbGeAlD
Ergotamine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00114	0.0194	CbGeAlD
Ergotamine—Lisuride—DRD4—Gilles de la Tourette syndrome	0.00105	0.12	CrCbGaD
Ergotamine—ADRA1B—brain—Gilles de la Tourette syndrome	0.00099	0.0168	CbGeAlD
Ergotamine—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000978	0.0166	CbGeAlD
Ergotamine—Bromocriptine—DRD4—Gilles de la Tourette syndrome	0.000973	0.111	CrCbGaD
Ergotamine—ADRA1D—brain—Gilles de la Tourette syndrome	0.000968	0.0164	CbGeAlD
Ergotamine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00096	0.0163	CbGeAlD
Ergotamine—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000947	0.0161	CbGeAlD
Ergotamine—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000942	0.016	CbGeAlD
Ergotamine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000938	0.0159	CbGeAlD
Ergotamine—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000912	0.0155	CbGeAlD
Ergotamine—Lisuride—DRD3—Gilles de la Tourette syndrome	0.000906	0.103	CrCbGaD
Ergotamine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000903	0.0153	CbGeAlD
Ergotamine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000881	0.015	CbGeAlD
Ergotamine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000867	0.0147	CbGeAlD
Ergotamine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000848	0.0144	CbGeAlD
Ergotamine—Bromocriptine—DRD3—Gilles de la Tourette syndrome	0.000839	0.0956	CrCbGaD
Ergotamine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000789	0.0134	CbGeAlD
Ergotamine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000782	0.0133	CbGeAlD
Ergotamine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.00076	0.0129	CbGeAlD
Ergotamine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000753	0.0128	CbGeAlD
Ergotamine—HTR1B—brain—Gilles de la Tourette syndrome	0.000747	0.0127	CbGeAlD
Ergotamine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000727	0.0124	CbGeAlD
Ergotamine—HTR1D—brain—Gilles de la Tourette syndrome	0.000724	0.0123	CbGeAlD
Ergotamine—Methylergometrine—HTR2A—Gilles de la Tourette syndrome	0.000722	0.0823	CrCbGaD
Ergotamine—HTR2C—brain—Gilles de la Tourette syndrome	0.000717	0.0122	CbGeAlD
Ergotamine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000713	0.0121	CbGeAlD
Ergotamine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.0007	0.0119	CbGeAlD
Ergotamine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000687	0.0117	CbGeAlD
Ergotamine—HTR2B—brain—Gilles de la Tourette syndrome	0.000673	0.0114	CbGeAlD
Ergotamine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000673	0.0114	CbGeAlD
Ergotamine—Lisuride—DRD2—Gilles de la Tourette syndrome	0.000627	0.0714	CrCbGaD
Ergotamine—HTR1A—brain—Gilles de la Tourette syndrome	0.000603	0.0102	CbGeAlD
Ergotamine—Methysergide—HTR2A—Gilles de la Tourette syndrome	0.000603	0.0687	CrCbGaD
Ergotamine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000598	0.0102	CbGeAlD
Ergotamine—Bromocriptine—DRD2—Gilles de la Tourette syndrome	0.000581	0.0662	CrCbGaD
Ergotamine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000572	0.00972	CbGeAlD
Ergotamine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000556	0.00944	CbGeAlD
Ergotamine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000553	0.00939	CbGeAlD
Ergotamine—DRD2—brain—Gilles de la Tourette syndrome	0.000545	0.00926	CbGeAlD
Ergotamine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000533	0.00904	CbGeAlD
Ergotamine—Lisuride—HTR2A—Gilles de la Tourette syndrome	0.000484	0.0552	CrCbGaD
Ergotamine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.00047	0.00799	CbGeAlD
Ergotamine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000453	0.00769	CbGeAlD
Ergotamine—Bromocriptine—HTR2A—Gilles de la Tourette syndrome	0.000449	0.0511	CrCbGaD
Ergotamine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000435	0.00739	CbGeAlD
Ergotamine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000423	0.00718	CbGeAlD
Ergotamine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000419	0.00712	CbGeAlD
Ergotamine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000375	0.00637	CbGeAlD
Ergotamine—HTR2A—brain—Gilles de la Tourette syndrome	0.000359	0.00611	CbGeAlD
Ergotamine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000308	0.00523	CbGeAlD
Ergotamine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000297	0.00504	CbGeAlD
Ergotamine—ABCB1—brain—Gilles de la Tourette syndrome	0.000236	0.004	CbGeAlD
Ergotamine—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000111	0.000731	CbGpPWpGaD
Ergotamine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000111	0.000731	CbGpPWpGaD
Ergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00011	0.000726	CbGpPWpGaD
Ergotamine—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.000725	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00011	0.000724	CbGpPWpGaD
Ergotamine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000109	0.000722	CbGpPWpGaD
Ergotamine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000109	0.000717	CbGpPWpGaD
Ergotamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000108	0.000716	CbGpPWpGaD
Ergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000108	0.000715	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000107	0.000704	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000106	0.000703	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000106	0.000701	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000105	0.000693	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000105	0.000691	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000104	0.000684	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000103	0.000683	CbGpPWpGaD
Ergotamine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000103	0.000683	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000103	0.000681	CbGpPWpGaD
Ergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000103	0.000681	CbGpPWpGaD
Ergotamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000103	0.000681	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000103	0.000681	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000103	0.000679	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000102	0.000673	CbGpPWpGaD
Ergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.000667	CbGpPWpGaD
Ergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000101	0.000666	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0001	0.000663	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.97e-05	0.000659	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.95e-05	0.000657	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.91e-05	0.000655	CbGpPWpGaD
Ergotamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.89e-05	0.000654	CbGpPWpGaD
Ergotamine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	9.83e-05	0.000649	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.66e-05	0.000638	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.6e-05	0.000634	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.58e-05	0.000633	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	9.55e-05	0.000631	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.49e-05	0.000627	CbGpPWpGaD
Ergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.49e-05	0.000627	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	9.39e-05	0.00062	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	9.35e-05	0.000618	CbGpPWpGaD
Ergotamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.3e-05	0.000614	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.3e-05	0.000614	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.29e-05	0.000614	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	9.27e-05	0.000612	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.25e-05	0.000611	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.2e-05	0.000608	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	9.11e-05	0.000602	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9e-05	0.000594	CbGpPWpGaD
Ergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.000593	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.98e-05	0.000593	CbGpPWpGaD
Ergotamine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.93e-05	0.00059	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.93e-05	0.00059	CbGpPWpGaD
Ergotamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.83e-05	0.000583	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.81e-05	0.000582	CbGpPWpGaD
Ergotamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	8.79e-05	0.000581	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.67e-05	0.000572	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	8.63e-05	0.00057	CbGpPWpGaD
Ergotamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.55e-05	0.000565	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.55e-05	0.000565	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	8.49e-05	0.000561	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.36e-05	0.000553	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.32e-05	0.00055	CbGpPWpGaD
Ergotamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	8.13e-05	0.000537	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.12e-05	0.000536	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.99e-05	0.000528	CbGpPWpGaD
Ergotamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000526	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.97e-05	0.000526	CbGpPWpGaD
Ergotamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.88e-05	0.000521	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.88e-05	0.000521	CbGpPWpGaD
Ergotamine—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.85e-05	0.000519	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.82e-05	0.000517	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.76e-05	0.000512	CbGpPWpGaD
Ergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.69e-05	0.000508	CbGpPWpGaD
Ergotamine—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.69e-05	0.000508	CbGpPWpGaD
Ergotamine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.65e-05	0.000506	CbGpPWpGaD
Ergotamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.6e-05	0.000502	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.6e-05	0.000502	CbGpPWpGaD
Ergotamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.33e-05	0.000484	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.27e-05	0.00048	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.23e-05	0.000477	CbGpPWpGaD
Ergotamine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.22e-05	0.000477	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.08e-05	0.000467	CbGpPWpGaD
Ergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.06e-05	0.000466	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.06e-05	0.000466	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.01e-05	0.000463	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	6.97e-05	0.00046	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.94e-05	0.000458	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.86e-05	0.000453	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.000449	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.75e-05	0.000446	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.72e-05	0.000444	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.66e-05	0.00044	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.57e-05	0.000434	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	6.55e-05	0.000432	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.51e-05	0.00043	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.45e-05	0.000426	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.36e-05	0.00042	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.34e-05	0.000419	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.3e-05	0.000416	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.26e-05	0.000413	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.23e-05	0.000412	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.21e-05	0.00041	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.18e-05	0.000408	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.07e-05	0.000401	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.05e-05	0.0004	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.05e-05	0.000399	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6e-05	0.000396	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.95e-05	0.000393	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.88e-05	0.000388	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.86e-05	0.000387	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.85e-05	0.000387	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.83e-05	0.000385	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.83e-05	0.000385	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.82e-05	0.000385	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.76e-05	0.00038	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.71e-05	0.000377	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.68e-05	0.000375	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.64e-05	0.000372	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.58e-05	0.000369	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.55e-05	0.000366	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.45e-05	0.00036	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.42e-05	0.000358	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.41e-05	0.000358	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	5.38e-05	0.000356	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.32e-05	0.000351	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.29e-05	0.00035	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.29e-05	0.000349	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.26e-05	0.000347	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.23e-05	0.000345	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.2e-05	0.000343	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.14e-05	0.00034	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.07e-05	0.000335	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.05e-05	0.000333	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.02e-05	0.000331	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.98e-05	0.000329	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.96e-05	0.000327	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.93e-05	0.000325	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.92e-05	0.000325	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.9e-05	0.000323	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.83e-05	0.000319	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	4.82e-05	0.000318	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.77e-05	0.000315	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.75e-05	0.000314	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.73e-05	0.000312	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.72e-05	0.000312	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.7e-05	0.000311	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.61e-05	0.000304	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.6e-05	0.000304	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.59e-05	0.000303	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.58e-05	0.000303	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.52e-05	0.000299	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.52e-05	0.000298	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.5e-05	0.000297	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.46e-05	0.000294	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.45e-05	0.000294	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000293	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.42e-05	0.000292	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.39e-05	0.00029	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.38e-05	0.00029	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.35e-05	0.000287	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.29e-05	0.000284	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.29e-05	0.000284	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.27e-05	0.000282	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.000275	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.11e-05	0.000271	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.1e-05	0.000271	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.09e-05	0.00027	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.08e-05	0.00027	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.08e-05	0.00027	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.05e-05	0.000267	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000266	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.02e-05	0.000265	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4e-05	0.000264	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.99e-05	0.000263	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.98e-05	0.000263	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.95e-05	0.000261	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.9e-05	0.000257	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	3.85e-05	0.000254	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.8e-05	0.000251	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.76e-05	0.000248	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.73e-05	0.000246	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.72e-05	0.000246	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.72e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.71e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.71e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000243	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.65e-05	0.000241	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.63e-05	0.00024	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.62e-05	0.000239	CbGpPWpGaD
Ergotamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.58e-05	0.000237	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000236	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.51e-05	0.000232	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.46e-05	0.000228	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.45e-05	0.000228	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.000227	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.4e-05	0.000225	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.37e-05	0.000223	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.36e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.00022	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.31e-05	0.000219	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.29e-05	0.000218	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.22e-05	0.000213	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.15e-05	0.000208	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000207	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.12e-05	0.000206	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.11e-05	0.000206	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000199	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000198	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	2.97e-05	0.000196	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.91e-05	0.000192	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.91e-05	0.000192	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.9e-05	0.000192	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.86e-05	0.000189	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.000186	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.8e-05	0.000185	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.8e-05	0.000185	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.79e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.72e-05	0.00018	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.71e-05	0.000179	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.67e-05	0.000176	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.63e-05	0.000174	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.6e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000171	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.54e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.54e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.52e-05	0.000167	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.000163	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.42e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.42e-05	0.00016	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.38e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.37e-05	0.000157	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.36e-05	0.000156	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.35e-05	0.000155	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000154	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.3e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.2e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.19e-05	0.000145	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000145	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.14e-05	0.000141	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.04e-05	0.000135	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.99e-05	0.000132	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.78e-05	0.000117	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.77e-05	0.000117	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.000112	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000103	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.5e-05	9.92e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.4e-05	9.22e-05	CbGpPWpGaD
